<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Erythrocyte complement receptor type 1 (CR1) was measured in 37 <z:mpath ids='MPATH_458'>normal</z:mpath> controls and in 95 patients with various <z:e sem="disease" ids="C0018939" disease_type="Disease or Syndrome" abbrv="">hematologic diseases</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Levels of erythrocyte CR1 were significantly decreased in patients with <z:hpo ids='HP_0004808'>acute myelocytic leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>), <z:hpo ids='HP_0011009'>acute</z:hpo> lymphocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> (ALL), <z:hpo ids='HP_0011010'>chronic</z:hpo> myelocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo>, non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (NHL), <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo>, <z:hpo ids='HP_0001973'>idiopathic thrombocytopenic purpura</z:hpo>, and <z:hpo ids='HP_0006775'>multiple myeloma</z:hpo> when compared to <z:mpath ids='MPATH_458'>normal</z:mpath> controls </plain></SENT>
<SENT sid="2" pm="."><plain>There was also a trend of recovery of erythrocyte CR1 levels in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> and ALL patients when they were in a state of complete remission compared to those at time of <z:hpo ids='HP_0003674'>onset</z:hpo> or relapse </plain></SENT>
<SENT sid="3" pm="."><plain>Further investigation is needed as to determine whether the level of erythrocyte CR1 can serve as a predictor for relapse of <z:hpo ids='HP_0001909'>leukemia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>This study also showed that the level of erythrocyte CR1 was not related to prognostic factors in NHL patients </plain></SENT>
</text></document>